during the speedily evolving field of cancer therapeutics, comprehending the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is critical for producing helpful treatment options. The most promising strategies is the use of in vitro bystander outcome assays, which Perform a pivotal position in boosting therapeutic efficacy. These assays, prov